Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022
AIDS and Behavior · 2025
DOI: 10.1007/s10461-025-04819-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Hunter C Spencer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Rd., PortlandPortland, OR, 97239, USA. spenc…. Hauptthemen laut MEDLINE: HIV Infections, Substance Abuse, Intravenous, Pre-Exposure Prophylaxis, Health Knowledge, Attitudes, Practice. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
HIV pre-exposure prophylaxis (PrEP) prevents HIV transmission. However, PrEP remains underutilized among people who inject drugs (PWID), even when clinically indicated. Here, we assess changes in PrEP awareness, access, and use in 2018 and 2022 and factors associated with PrEP awareness in 2022. We analyzed a sample of PWID not living with HIV with an indication for PrEP based on National HIV Behavioral Surveillance (NHBS) in Portland, Oregon during the 2018 and 2022 survey cycles. We compared PrEP awareness, access, and use in 2018 and 2022 with χ2. Using 2018 and 2022 data, we compared PrEP awareness between the two years with a Poisson regression. Using 2022 data, we assessed factors associated with PrEP awareness. Compared to 2018, PrEP awareness was higher in 2022 (33% vs 17%, p < 0.001, aPR = 1.24, 95% CI = 1.14-1.36). There were no significant differences in PrEP access or use between 2018 to 2022. In the 2022 sample, PrEP awareness was higher among those with Hispanic ethnicity compared to white, non-Hispanic PWID (aPR = 2.18, 95% CI = 1.21-3.90) and previous drug treatment (aPR = 1.79, 95% CI = 1.20-2.69). Although PrEP awareness was higher in 2022 than 2018, PrEP access and use were unchanged and remained rare. PrEP use among PWID remains insufficient to meet national Ending the HIV Epidemic goals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Internal Medicine, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Rd., PortlandPortland, OR, 97239, USA. spencerh@ohsu.edu.
- Chime In, HIV STI and TB Section, Oregon Health Authority, Portland, OR, USA.
- School of Social Work, Portland State University, Portland, OR, USA.
- School of Medicine, University of Washington, Seattle, WA, USA.
Förderung
- NCATS NIH HHS
- CDC HHS
- Centers for Disease Control and Prevention
- National Center for Advancing Translational Sciences
Zitieren
APA
Spencer, H. C., Town, M. A., Sevillano, L., Lipira, L., & Menza, T. W. (2025). Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04819-3
Vancouver
Spencer HC, Town MA, Sevillano L, Lipira L, Menza TW. Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022. AIDS and Behavior. 2025. doi:10.1007/s10461-025-04819-3
BibTeX
@article{Spencer2025,
author = {Spencer, Hunter C and Town, Matthew A and Sevillano, LaLaine and Lipira, Lauren and Menza, Tim W},
title = {Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022},
journal = {AIDS and Behavior},
year = {2025},
doi = {10.1007/s10461-025-04819-3}
}
EUVIMED